The poison pill adoption suggests the Board perceives a potential threat from an activist or acquirer accumulating a stake. Monitor for any Schedule 13D filings or public statements from large shareholders. The plan's one-year duration and low redemption price ($0.0001) give the Board flexibility to negotiate or block unsolicited approaches. No immediate trading catalyst.
Price Chart
Executive Summary
Greenland Mines Ltd adopted a limited-duration stockholder rights plan (poison pill) effective July 22, 2026, issuing one right per common share as a dividend to shareholders of record on August 7, 2026. The plan triggers at 15% beneficial ownership, with a flip-in provision allowing other holders to purchase shares at a 50% discount, and expires on July 22, 2027. This defensive measure signals potential activist or takeover interest but does not provide any financial data or immediate operational catalyst.
Key Facts
- Board declared a dividend of one Right per outstanding common share, payable August 7, 2026 to holders of record.
- Rights become exercisable if a person or group acquires beneficial ownership of 15% or more of outstanding common shares.
- Upon trigger, each Right (excluding the acquiring person) entitles holder to purchase common shares at a 50% discount to market value.
- Exercise price is $0.75 per Right, subject to anti-dilution adjustments.
- Plan expires on July 22, 2027, unless earlier redeemed or exchanged by the Board, or if stockholder approval not obtained at the 2027 annual meeting.
- Board may redeem all Rights at $0.0001 per Right at any time before a person becomes an Acquiring Person.
- Existing holders of 15% or more as of July 22, 2026 are grandfathered but cannot increase ownership by 0.20% or more without triggering the plan.
Financial Impact
No financial impact from adoption; potential dilutive impact if triggered (rights exercisable at 50% discount to market).
Risk Factors
- Plan may deter legitimate acquisition proposals that could benefit shareholders.
- If triggered, significant dilution could occur for the acquiring person.
- Stockholder approval required at 2027 annual meeting; failure to obtain could terminate the plan early.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-080649 |
| Document: ea0298948-8k_greenland.htm | 0001213900-26-080649 |
| Document: ea029894801ex99-1.htm | 0001213900-26-080649 |
| Document: 0001213900-26-080649-index-headers.html | 0001213900-26-080649 |
| Document: 0001213900-26-080649-index.html | 0001213900-26-080649 |
| Document: 0001213900-26-080649.txt | 0001213900-26-080649 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | S-1 | $5.76 | awaiting T+1 | — | $5.79 (+0.51%) |
Oct 6, 2026 21d ago | Press Release | $6.38 $5.83 | ▼ −8.62% | ▼ −8.38% | $5.79 (−9.25%) |
Oct 5, 2026 22d ago | Press Release | $7.34 $6.38 | ▼ −13.08% | ▼ −13.63% | $5.79 (−21.12%) |
Sep 24, 2026 4w ago | Press Release | $14.89 $14.66 | ▲ +1.54% | ▲ +2.09% | $5.79 (+61.11%) |
Sep 23, 2026 4w ago | 424B5 | $14.89 $14.66 | ▲ +1.54% | ▲ +2.09% | $5.79 (+61.11%) |
Sep 23, 2026 4w ago | 8-K | $14.89 $14.66 | ▲ +1.54% | ▲ +2.09% | $5.79 (+61.11%) |
Sep 23, 2026 4w ago | 424B5 | $11.19 $14.89 | ▲ +33.07% | ▲ +33.15% | $5.79 (−48.26%) |
Sep 23, 2026 4w ago | Press Release | $11.19 $14.89 | ▲ +33.07% | ▲ +33.15% | $5.79 (−48.26%) |
Sep 22, 2026 5w ago | Institutional Cluster | $14.15 $11.19 | ▼ −20.92% | ▼ −20.20% | $5.79 (−59.08%) |
Sep 21, 2026 5w ago | Press Release | $9.42 $14.15 | ▲ +50.21% | ▲ +50.23% | $5.79 (−38.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers